

Ensure health insurance covers hormone pellets for women FDA docket # FDA-2026-p-9152
The Issue
For years, I struggled with severe mood swings and tried countless treatments that simply didn't work for me. It wasn't until I discovered hormone replacement therapy (HRT) pellets that I finally found relief. Like many women in the U.S., I found this treatment to be the only one that effectively balanced my hormones and improved my quality of life. However, the high cost makes it inaccessible for many. If insrueance companies will cover hormones for trans, I believe everyone should have this avalable for them, (I am a women, I should have the right to continue feeling like a women)
The current standard-of-care model for menopausal and perimenopause management relies on an over-generalized approach that fails millions of women. Standard, mass-manufactured synthetic hormones use rigid, uniform dosing that does not account for individual biological variation. When these mass-market options fail, women are routinely placed on secondary medications like antidepressants, or left with severe, unmanaged symptoms—such as year-long continuous menstrual cycles, extreme emotional distress, and sudden weight gain—that can lead to severe career disruption and long-term disability.
Subcutaneous bioidentical hormone pellets and injections offer a uniquely effective therapeutic mechanism that standard options cannot replicate. By bypassing first-pass liver metabolism, pellets deliver a steady, continuous release of identical 17-beta estradiol and testosterone directly into the bloodstream, successfully eliminating the daily hormonal fluctuations that trigger debilitating mood swings and erratic bleeding. Furthermore, the clinical success of this treatment relies heavily on strict, localized, and proactive medical oversight. Patients undergo comprehensive blood panels every six weeks to actively track, evaluate, and adjust systemic levels. This meticulous, data-driven monitoring provides a level of patient-specific safety and precision regulation that equals or exceeds mass-marketed standards. Given that the FDA has already approved mass-manufactured subcutaneous hormone pellets for men, equity in women’s healthcare demands that the FDA recognize this data-backed, patient-specific delivery system and create a clear framework for formal approval.
Hormone pellets and injections offer a revolutionary approach to hormone replacement—providing a steady, consistent release that closely mimics the body's natural rhythms. Despite its effectiveness, this treatment is often not covered by health insurance, forcing many women to pay out-of-pocket or forgo treatment altogether. This is not just an issue of financial burden, but an urgent health concern affecting countless women who deserve affordable access to the care they need.
According to the Society for Women's Health Research, nearly 2 million women begin menopause every year in the United States, and many experience symptoms that drastically affect their daily lives. Hormone pellet and injection therapy can offer incredible benefits, relieving symptoms such as mood swings, fatigue, and more. Yet, without insurance coverage, this vital treatment remains out of reach for countless individuals.
The cost of ignoring this issue is significant—not only emotionally for the women suffering but also economically. A study by the North American Menopause Society shows that untreated menopausal symptoms lead to increased healthcare costs due to the need for more frequent doctor visits and treatment of secondary conditions like anxiety and depression.
We urge U.S. health insurers and lawmakers to prioritize women's health by including hormone pellet and injection therapy in their insurance coverage plans. By doing so, we can ensure that more women can access the care they need without the crippling financial burden. Investing in this coverage means investing in the emotional and physical well-being of countless women.
Join me in the fight for accessible women's healthcare and fair insurance coverage. Please sign this petition to call for mandatory coverage of hormone pellet therapy by health insurers in U.S. Together, we can make a difference in the lives of many women seeking the treatment they deserve.

16
The Issue
For years, I struggled with severe mood swings and tried countless treatments that simply didn't work for me. It wasn't until I discovered hormone replacement therapy (HRT) pellets that I finally found relief. Like many women in the U.S., I found this treatment to be the only one that effectively balanced my hormones and improved my quality of life. However, the high cost makes it inaccessible for many. If insrueance companies will cover hormones for trans, I believe everyone should have this avalable for them, (I am a women, I should have the right to continue feeling like a women)
The current standard-of-care model for menopausal and perimenopause management relies on an over-generalized approach that fails millions of women. Standard, mass-manufactured synthetic hormones use rigid, uniform dosing that does not account for individual biological variation. When these mass-market options fail, women are routinely placed on secondary medications like antidepressants, or left with severe, unmanaged symptoms—such as year-long continuous menstrual cycles, extreme emotional distress, and sudden weight gain—that can lead to severe career disruption and long-term disability.
Subcutaneous bioidentical hormone pellets and injections offer a uniquely effective therapeutic mechanism that standard options cannot replicate. By bypassing first-pass liver metabolism, pellets deliver a steady, continuous release of identical 17-beta estradiol and testosterone directly into the bloodstream, successfully eliminating the daily hormonal fluctuations that trigger debilitating mood swings and erratic bleeding. Furthermore, the clinical success of this treatment relies heavily on strict, localized, and proactive medical oversight. Patients undergo comprehensive blood panels every six weeks to actively track, evaluate, and adjust systemic levels. This meticulous, data-driven monitoring provides a level of patient-specific safety and precision regulation that equals or exceeds mass-marketed standards. Given that the FDA has already approved mass-manufactured subcutaneous hormone pellets for men, equity in women’s healthcare demands that the FDA recognize this data-backed, patient-specific delivery system and create a clear framework for formal approval.
Hormone pellets and injections offer a revolutionary approach to hormone replacement—providing a steady, consistent release that closely mimics the body's natural rhythms. Despite its effectiveness, this treatment is often not covered by health insurance, forcing many women to pay out-of-pocket or forgo treatment altogether. This is not just an issue of financial burden, but an urgent health concern affecting countless women who deserve affordable access to the care they need.
According to the Society for Women's Health Research, nearly 2 million women begin menopause every year in the United States, and many experience symptoms that drastically affect their daily lives. Hormone pellet and injection therapy can offer incredible benefits, relieving symptoms such as mood swings, fatigue, and more. Yet, without insurance coverage, this vital treatment remains out of reach for countless individuals.
The cost of ignoring this issue is significant—not only emotionally for the women suffering but also economically. A study by the North American Menopause Society shows that untreated menopausal symptoms lead to increased healthcare costs due to the need for more frequent doctor visits and treatment of secondary conditions like anxiety and depression.
We urge U.S. health insurers and lawmakers to prioritize women's health by including hormone pellet and injection therapy in their insurance coverage plans. By doing so, we can ensure that more women can access the care they need without the crippling financial burden. Investing in this coverage means investing in the emotional and physical well-being of countless women.
Join me in the fight for accessible women's healthcare and fair insurance coverage. Please sign this petition to call for mandatory coverage of hormone pellet therapy by health insurers in U.S. Together, we can make a difference in the lives of many women seeking the treatment they deserve.

The Decision Makers
Petition Updates
Share this petition
Petition created on August 12, 2026